Back to Journals » ClinicoEconomics and Outcomes Research » Volume 10

Clinical and economic impact of the 21-gene recurrence score assay in adjuvant therapy decision making in patients with early-stage breast cancer: pooled analysis in 4 Basque Country university hospitals

Total article views   Abstract views HTML views PDF downloads Totals
4,687 Dovepress* 3,961 489+ 859 4,450
PubMed Central* 0 237 64 237
Totals 3,961 726 923 4,687
*Since 19 March 2018
+Since July 2016

View citations on PubMed Central and Google Scholar